Immune checkpoint inhibitors may play a role in the management of patients with certain gastroesophageal cancers. Join a leading oncology expert to review extended follow-up clinical trial data for an Immuno-Oncology (I-O)-based regimen used across certain metastatic gastroesophageal cancers. This is also an opportunity to ask questions to better understand the treatment landscape. Key Takeaways:…
